At this time, posts about BioSmart are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 5,000 shares of BioSmart, while institutions have sold a net 31,000 shares. BioSmart is known as a manufacturer of credit cards and cosmetics, as well as a distributor.
As of 11:30 AM on the 29th, BioSmart's stock price is 10,350 KRW, down 2.82% from the previous day, with a trading volume of 4,154,512 shares, which is 129.74% of the 5-day average trading volume. On October 27, BioSmart became a market issue with a 29% increase following the news of FDA emergency approval for its COVID-19 diagnostic kit.
In addition to BioSmart, posts by investors are also rapidly increasing for KoreaCenter (290510), LegoChem Bio (141080), and Aju IB Investment (027360).

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

